Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) Coupons, Discounts & Cost
Benicar HCT (olmesartan medoxomil + hydrochlorothiazide) is a combined antihypertensive agent. One way to save money on the Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) retail cost regardless of income and insurance status is to use Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) coupons or discount cards from RXCoupons. Use this Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) coupon at this online pharmacy and receive up to 75% off the sale price.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) drug information
Benicar HCT (olmesartan medoxomil + hydrochlorothiazide) is a combined antihypertensive agent.
Hydrochlorothiazide is a benzothiadiazepine derivative that removes from the body sodium, potassium, chloride, calcium and magnesium ions. Hydrochlorothiazide is effective in acidosis and alkalosis.
Olmesartan medoxomil blocks the conversion of angiotensin I into angiotensin II. Olmesartan decreases total peripheral vascular resistance without affecting heart rate.
Benicar HCT is used to treat hypertension and chronic heart failure. It helps reduce high blood pressure. Furthermore, it reduces polyuria in patients with diabetes. In some cases, it is used to reduce intraocular pressure in glaucoma.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) contraindications
The drug is contraindicated in severe renal and hepatic failure, congenital angioneurotic edema, patients on hemodialysis, during pregnancy and lactation, in patients under 18 years.
Use with caution in bronchial asthma, coronary heart disease, gout, psoriasis, autoimmune disorders of connective tissue, hypersensitivity.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) during pregnancy and lactation
Benicar HCT (olmesartan) is contraindicated during pregnancy and lactation.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) side effects
Hydrochlorothiazide side effects: Central and peripheral nervous system: headache, dizziness, depression, sleep disturbance, paresthesia. Respiratory system: pneumonia, pulmonary edema. Hematopoietic system: thrombocytopenia, agranulocytosis, leukopenia, hemolytic anemia. Cardiovascular system: orthostatic hypotension, rarely - arrhythmias. Musculoskeletal system: leg cramps. Dermatological reactions: photosensitivity, rash, rarely - toxic epidermal necrolysis. Urinary system: glycosuria, hyperuricemia. Reproductive system: impotence. Other reactions: blurred vision.
Olmesartan medoxomil side effects: Central and peripheral nervous system: headaches, dizziness, sleep disturbances, paresthesia, confusion. Respiratory system: dry cough, shortness of breath, sinusitis, bronchospasm. Cardiovascular system: hypotension, tachycardia, rarely - pain in the chest, hot flushes. Musculoskeletal system: myalgia, leg cramps. Hematopoietic system: anemia, thrombocytopenia, agranulocytosis, pancytopenia. Digestive system: glossitis, vomiting, diarrhea, constipation, rarely - hepatitis, cholestatic jaundice, pancreatitis. Dermatological reactions: rash. Urinary System: dysuria, rarely - acute renal failure. Reproductive system: erectile dysfunction. Other reactions: tinnitus, blurred vision, allergic reactions.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) overdose
Symptoms you might experience in case of Benicar HCT (olmesartan) overdose: marked decrease of blood pressure, electrolyte imbalance, bradycardia, cardiovascular shock, renal failure.
Treatment: administration of intravenous epinephrine, hydrocortisone.
Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) interaction
Hydrochlorothiazide: Hydrochlorothiazide enhances the effects of non-depolarizing muscle relaxants. Patients with diabetes (who take Benicar HTC) should correct the doses of oral hypoglycemic agents and insulin medications. Hydrochlorothiazide should not be used with corticosteroids, adrenocorticotropic hormone, carbenoxolone, amphotericin, cardiac glycosides. Anticholinergic drugs may increase the bioavailability of hydrochlorothiazide. Vitamin D and calcium supplements may cause hypercalcemia in patients taking hydrochlorothiazide. Cyclosporine increases the risk of gout and hyperuricemia.
Olmesartan medoxomil: Olmesartan medoxomil enhances hypoglycemic effects of insulin and oral hypoglycemic drugs. This agent enhances the toxic effects of medicines containing lithium. Sodium chloride and nonsteroidal anti-inflammatory drugs reduce the antihypertensive effect of olmesartan medoxomil. Potassium-sparing diuretics (amiloride, triamterene, spironolactone) and foods high in potassium may cause hyperkalemia. Cytostatics, allopurinol, systemic corticosteroids, procainamide, and immunosuppressants may increase the risk of leukopenia. Drugs for general and local anesthesia may cause hypotension.
Benicar HTC special instructions
Do not use other antihypertensive agents in combination therapy with Benicar HCT (olmesartan). Ethanol (alcohol), barbiturates, opioids or antidepressants can exacerbate orthostatic hypotension in patients taking Benicar HCT.
Caution should be exercised when driving or performing potentially hazardous activities that require high concentration during treatment with Benicar HCT.